Recent Updates
Recently added Catalysts
IONS

ISIS Initiates Phase 1 Clinical Trial of ISIS-SOD1Rx in Patients With ALS

Friday, March 5, 2010 1 min read
Key Takeaway: ISIS Initiates Phase 1 Clinical Trial of ISIS-SOD1Rx in Patients With ALS

Full Press Release Details

ISIS Initiates Phase 1 Clinical Trial of ISIS-SOD1Rx in Patients With ALS.
Tags: IONS Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Mar 5, 2010